uniQure N.V.
QURE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590560
In the last 90 days, uniQure N.V. insiders filed 0 open-market purchases and 3 sales; 254 institutions reported holding it in 13F filings for Q2 2026, worth $3.02B in total; Maverick Capital is the only superinvestor holding it.
Holders of 5% or more of QURE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of uniQure N.V., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 13G/A | 9.87%6.15M shares | +3.27 ppfrom 6.60% | Aug 14, 20252 filings | Feb 17, 2026 | SEC |
| JPMorgan Chase & Co | 13G | 7.00%4.87M shares | New | Jul 16, 20261 filing | Jul 16, 2026 | SEC |
| RTW Investments, LP | 13G | 5.70%3.94M shares | +1.60 ppfrom 4.10% | May 15, 20256 filings | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
61 Schedule 13D and 13G filings on uniQure N.V., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 11, 2022 | Point72 Asset Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 10, 2022 | Invesco Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 7, 20224:41 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Apr 30, 2021 | Coller International Partners V A LP | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | ForUniqure B.V. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Invesco Ltd. | 13GOld format | – | New | – | SEC |
| Feb 12, 20211:12 PM ET | Federated Hermes, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Nantahala Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
42 notices from officers, directors and other affiliates planning to sell uniQure N.V. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jul 2, 20264:00 PM ET | Kapusta Matthew COfficer · Director · CEO AND MANAGING DIRECTOR | 21.1K | $951.9K | Jul 2, 202610b5-1 | CITIGROUP GLOBAL MARKETS | SEC |
| Jun 30, 20264:01 PM ET | Abi-Saab WalidChief Medical Officer | 30.0K | $1.39M | Jun 30, 202610b5-1 | Citigroup Global Markets, Inc | SEC |
| Jun 30, 20264:00 PM ET | Kaye JackDirector | 21.2K | $983.0K | Jun 30, 202610b5-1 | Citigroup Global Markets, Inc | SEC |
| Jun 26, 20264:06 PM ET | Abi-Saab WalidChief Medical Officer | 1.43K | $67.2K | Jun 26, 2026 | Citigroup Global Markets, Inc | SEC |
| Jun 25, 20264:00 PM ET | Kapusta Matthew COfficer · Director · CEO AND MANAGING DIRECTOR | 28.7K | $1.44M | Jun 25, 202610b5-1 | CITIGROUP GLOBAL MARKETS | SEC |
| Jun 24, 20264:01 PM ET | Kapusta Matthew COfficer · Director · CEO AND MANAGING DIRECTOR | 6.70K | $334.8K | Jun 24, 202610b5-1 | CITIGROUP GLOBAL MARKETS | SEC |
| Jun 18, 20265:57 PM ET | Kapusta Matthew COfficer · Director · CEO AND MANAGING DIRECTOR | 41.7K | $1.93M | Jun 18, 202610b5-1 | CITIGROUP GLOBAL MARKETS | SEC |
| Jun 17, 20268:07 PM ET | Kapusta Matthew COfficer · Director · CEO AND MANAGING DIRECTOR | 164.4K | $7.07M | Jun 17, 202610b5-1 | CITIGROUP GLOBAL MARKETS | SEC |
| Jun 17, 20264:34 PM ET | Kaye JackDirector | 5.29K | $225.4K | Jun 17, 202610b5-1 | Citigroup Global Markets, Inc | SEC |
| Jun 17, 20264:03 PM ET | Balachandran MadhavanDirector | 11.7K | $526.5K | Jun 17, 202610b5-1 | Citigroup Global Markets, Inc | SEC |
| Jun 15, 20264:00 PM ET | Potts JeannetteOfficer · CHIEF LEGAL OFFICER | 5.24K | $144.9K | Jun 15, 2026 | CITIGROUP GLOBAL MARKETS | SEC |
| Jun 11, 20264:39 PM ET | O'Keefe KylieOfficer · Chief Customer and Strategy Officer | 15.9K | $431.3K | Jun 11, 2026 | CITIGROUP GLOBAL MARKETS | SEC |
| Jun 11, 20264:29 PM ET | Balachandran MadhavanDirector | 12.0K | $324.6K | Jun 11, 202610b5-1 | Citigroup Global Markets, Inc | SEC |
| Jun 11, 20264:25 PM ET | Gut RobertDirector | 2.73K | $73.8K | Jun 11, 2026 | Citigroup Global Markets, Inc | SEC |
| Jun 11, 20264:23 PM ET | Springhorn Jeremy P.Director | 1.99K | $53.9K | Jun 11, 2026 | Citigroup Global Markets, Inc | SEC |
| Jun 11, 20264:22 PM ET | Jacques Rachelle SuzanneDirector | 1.99K | $53.9K | Jun 11, 2026 | Citigroup Global Markets, Inc | SEC |
| Jun 11, 20264:20 PM ET | Post Leonard EDirector | 1.99K | $53.9K | Jun 11, 2026 | Citigroup Global Markets, Inc | SEC |
| Jun 11, 20264:19 PM ET | Meek David D.Director | 1.99K | $53.9K | Jun 11, 2026 | Citigroup Global Markets, Inc | SEC |
| Jun 11, 20264:18 PM ET | Kaye JackDirector | 1.99K | $53.9K | Jun 11, 2026 | Citigroup Global Markets, Inc | SEC |
| Jun 10, 20264:00 PM ET | Gut RobertDirector | 7.55K | $196.7K | Jun 10, 202610b5-1 | Citigroup Global Markets, Inc | SEC |
| Jun 3, 20263:58 PM ET | Kaye JackDirector | 2.65K | $79.4K | Jun 3, 202610b5-1 | Citigroup Global Markets, Inc. | SEC |
| May 8, 20264:00 PM ET | Abi-Saab WalidChief Medical Officer | 45.0K | $1.13M | May 8, 202610b5-1 | Citigroup Global Markets, Inc | SEC |
| Mar 4, 20264:56 PM ET | Potts JeannetteOfficer · CHIEF LEGAL AND COMPLIANCE OFFICER | 3.41K | $30.9K | Mar 4, 2026 | CITIGROUP GLOBAL MARKETS | SEC |
| Mar 4, 20264:50 PM ET | Klemt ChristianOfficer · CFO | 12.0K | $108.8K | Mar 4, 2026 | CITIGROUP GLOBAL MARKETS | SEC |
| Mar 4, 20264:46 PM ET | Kapusta Matthew CDirector | 14.6K | $132.2K | Mar 4, 2026 | CITIGROUP GLOBAL MARKETS | SEC |
Showing the latest 25. See the QURE notices from the last 12 months